Submit Deal

NEOPHARMED GENTILI

HQ - Milan

Summary

Neopharmed Gentili is an Italian pharmaceutical company known for its high-therapeutic value solutions and its expansion beyond national borders.

Deals Overview

Total Deals5

Valued Deals1

Total Value£ 192 M

Avg. Deal Size£ 192 M

Market Context

Senior Management

Alessandro Del Bono
President and CEO
Angela Del Giudice
Communications Director

Sort

28 Nov 2018|Italy|Pharmaceuticals

Target: NEOPHARMED GENTILI

Bidder: ARDIAN

10 Service Providers

3 Target | 7 Bidder

16 Dealmakers

5 Target | 11 Bidder

n/a

Value

31 Oct 2019|Italy|Pharmaceuticals

Target: MDM

Bidder: ARDIAN

10 Service Providers

3 Target | 7 Bidder

16 Dealmakers

2 Target | 14 Bidder

n/a

Value

09 Nov 2022|Italy|Pharmaceuticals

Target: NEOPHARMED GENTILI

Bidder: NB RENAISSANCE PARTNERS

13 Service Providers

2 Target | 5 Bidder | 6 Vendor

23 Dealmakers

9 Target | 6 Bidder | 9 Vendor

n/a

Value

25 Jul 2022|Italy|Pharmaceuticals

Target: VALEAS SPA

Bidder: ARDIAN

4 Service Providers

3 Target | 1 Bidder

12 Dealmakers

11 Target | 1 Bidder

n/a

Value

27 Jun 2025|Ireland|Pharmaceuticals

Target: ORLADEYO (BEROTRALSTAT BUSINESS)

Bidder: NEOPHARMED GENTILI

7 Service Providers

3 Bidder | 4 Vendor

13 Dealmakers

1 Bidder | 12 Vendor

£ 192 M

Value

By continuing, you agree to our Terms & Conditions and our Data Privacy Policy